These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 17404170)
1. Cytomegalovirus infection and cardiac allograft vasculopathy in children. Webber SA Circulation; 2007 Apr; 115(13):1701-2. PubMed ID: 17404170 [No Abstract] [Full Text] [Related]
2. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children. Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448 [TBL] [Abstract][Full Text] [Related]
3. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. Everett JP; Hershberger RE; Norman DJ; Chou S; Ratkovec RM; Cobanoglu A; Ott GY; Hosenpud JD J Heart Lung Transplant; 1992; 11(3 Pt 2):S133-7. PubMed ID: 1320405 [TBL] [Abstract][Full Text] [Related]
4. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy. Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004 [TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus infection in kidney transplantation: prophylaxis and management. Bulinski P; Toledo-Pereyra LH; Dalal S; Hernandez G Transplant Proc; 1996 Dec; 28(6):3310-1. PubMed ID: 8962286 [No Abstract] [Full Text] [Related]
7. Direct and indirect effects of cytomegalovirus: can we prevent them? Razonable R Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):1-5. PubMed ID: 20022410 [No Abstract] [Full Text] [Related]
8. Role of cytomegalovirus in cardiac allograft vasculopathy. Weill D Transpl Infect Dis; 2001; 3 Suppl 2():44-8. PubMed ID: 11926750 [TBL] [Abstract][Full Text] [Related]
9. The relationship of epidemiology and treatment factors to infection and allograft survival in renal transplantation. Betts RF Birth Defects Orig Artic Ser; 1984; 20(1):87-99. PubMed ID: 6329375 [No Abstract] [Full Text] [Related]
10. Acute rejection and cytomegalovirus infection: correlation with cardiac allograft vasculopathy. Mangiavacchi M; Frigerio M; Gronda E; Danzi GB; Bonacina E; Masciocco G; Olivia F; De Vita C; Pellegrini A Transplant Proc; 1995 Jun; 27(3):1960-2. PubMed ID: 7792851 [No Abstract] [Full Text] [Related]
11. The pathogenesis and clinical management of cytomegalovirus infection in the organ transplant recipient: the end of the 'silo hypothesis'. Rubin RH Curr Opin Infect Dis; 2007 Aug; 20(4):399-407. PubMed ID: 17609600 [TBL] [Abstract][Full Text] [Related]
12. Benefits of cytomegalovirus prophylaxis in solid organ transplantation. Pescovitz MD Transplantation; 2006 Jul; 82(2 Suppl):S4-8. PubMed ID: 16858270 [TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection after liver transplantation. Chen YS; Chen CL; Kuo YC; Sun CK Transplant Proc; 1994 Aug; 26(4):2229-30. PubMed ID: 8066728 [No Abstract] [Full Text] [Related]